DGAP-News
PAION AG: ANNUAL GENERAL MEETING APPROVES ALL AGENDA ITEMS AND ELECTS MICHAEL SCHLENK AND GREGOR SIEBERT TO THE SUPERVISORY BOARD
DGAP-News: PAION AG / Key word(s): AGM/EGM PAION AG: ANNUAL GENERAL MEETING APPROVES ALL AGENDA ITEMS AND ELECTS MICHAEL SCHLENK AND GREGOR SIEBERT TO THE SUPERVISORY BOARD |
- Agenda items approved with a large majority
- Michael Schlenk and Gregor Siebert elected as successors to Dr Dr Antonijevic and Dr Jörg Spiekerkötter; Dr Hans Christoph Tanner re-elected
Aachen (Germany), 25 May 2022 – PAION AG, a specialty pharma company (ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard: PA8), today announces that the Annual General Meeting of the company on 25 May 2022 approved the proposed resolutions submitted by the Management Board and the Supervisory Board with a large majority. The results are available on the company's website www.paion.com/medien-investoren/hauptversammlung.
In addition, Michael Schlenk and Gregor Siebert were elected to the Supervisory Board, replacing Dr Dr Irina Antonijevic and Dr Jörg Spiekerkötter. Mr Schlenk will take over the chairmanship of the Supervisory Board from Dr Spiekerkötter. In addition, Dr Hans Christoph Tanner was re-elected as a member of the Supervisory Board.
"We are delighted to have gained two recognised experts from the pharmaceutical industry as members of PAION AG's Supervisory Board. With their expertise, they will be able to make important contributions to PAION's future development," said Dr. Jörg Spiekerkötter, outgoing Chairman of the Supervisory Board of PAION AG. "For me, this was the last Annual General Meeting of PAION AG after 15 years. I would like to express my heartfelt thanks to all employees and partners who have contributed to the company's development. I am convinced that PAION will be successful with its products and wish the company and its employees every success. "